Recent CHRS News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/09/2026 08:56:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 08:40:39 PM
- Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/09/2026 08:15:00 PM
- Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026 • GlobeNewswire Inc. • 03/02/2026 02:30:00 PM
- Coherus Oncology to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/23/2026 02:30:00 PM
- Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock • GlobeNewswire Inc. • 02/17/2026 09:11:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 09:05:33 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/13/2026 10:10:53 PM
- Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock • GlobeNewswire Inc. • 02/13/2026 02:18:21 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/12/2026 09:08:22 PM
- Coherus Oncology, Inc. Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 02/12/2026 09:05:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/05/2026 03:25:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/04/2026 01:40:28 PM
- Registration-Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks • PR Newswire (Canada) • 01/27/2026 03:50:00 PM
- Registration-Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks • PR Newswire (US) • 01/27/2026 03:50:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2026 09:39:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2026 10:27:26 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/23/2026 10:26:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2026 01:50:42 AM
- Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape • PR Newswire (Canada) • 01/16/2026 01:00:00 PM
- Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape • PR Newswire (US) • 01/16/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2026 02:00:28 PM
- The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff • GlobeNewswire Inc. • 01/12/2026 03:14:09 PM
- Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/06/2026 02:30:00 PM
- SpyGlass Pharma Appoints Jean-Frédéric Viret as Chief Financial Officer • GlobeNewswire Inc. • 01/06/2026 01:00:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
